Tectonic Therapeutic (TECX) Assets Average (2018 - 2026)
Tectonic Therapeutic's (TECX) quarterly Assets Average came in at $253.8 million in Q1 2026, up 8.53% year-on-year from $233.9 million in Q1 2025, and down 5.65% on a QoQ basis from $269.0 million in Q4 2025.
Tectonic Therapeutic (TECX) Assets Average (2018 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Assets Average data on file, last reported at $253.8 million in Q1 2026.
- On a quarterly basis, Assets Average rose 8.53% year-over-year to $253.8 million in Q1 2026; TTM through Mar 2026 was $253.8 million, a 8.53% increase from a year earlier, with the FY2025 full-year figure at $207.0 million, up 115.25% from the prior year.
- Assets Average for Q1 2026 stood at $253.8 million, down from $269.0 million in the prior quarter.
- Over the last five years, Assets Average for TECX reached as high as $305.1 million in Q2 2025 and fell as low as $65.9 million in Q1 2024.
- Historically, Assets Average has averaged $170.8 million across 5 years, with a median of $160.8 million in 2022.
- Across the five-year window, Assets Average slumped 50.7% in 2023 and surged 255.02% in 2025, its largest moves.
- Year by year, Assets Average stood at $116.7 million in 2022, then plunged by 35.78% to $75.0 million in 2023, then soared by 114.53% to $160.8 million in 2024, then surged by 67.29% to $269.0 million in 2025, then slipped by 5.65% to $253.8 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $253.8 million in Q1 2026, $269.0 million in Q4 2025, and $286.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | 253.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.81 Mn |
| Dec 31, 2025 | 269.02 Mn |
| Sep 30, 2025 | 286.16 Mn |
| Jun 30, 2025 | 305.07 Mn |
| Mar 31, 2025 | 233.87 Mn |
| Dec 31, 2024 | 160.81 Mn |
| Sep 30, 2024 | 181.31 Mn |
| Jun 30, 2024 | 143.13 Mn |
| Mar 31, 2024 | 65.87 Mn |
| Dec 31, 2023 | 74.96 Mn |
| Sep 30, 2023 | 122.18 Mn |
| Jun 30, 2023 | 108.42 Mn |
| Mar 31, 2023 | 93.48 Mn |
| Dec 31, 2022 | 116.72 Mn |
| Sep 30, 2022 | 137.87 Mn |
| Jun 30, 2022 | 160.79 Mn |
| Mar 31, 2022 | 189.59 Mn |
| Dec 31, 2021 | 210.15 Mn |
| Sep 30, 2021 | 227.27 Mn |
| Jun 30, 2021 | 242.00 Mn |